Megan O'Toole, DO
Surgery · San Antonio, TXNPI 1780827949
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,378 of the $8,122 with a category attached, or 66.2%. 16 manufacturers reported payments, led by TELA Bio, Inc. at 32.6% of the total. Reporting peaked in 2021 at $3,194 and has fallen 82.9% since, to $545 in 2025.
Across 79 payments — averaging $102.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$3K
- Stryker$2K
- Musculoskeletal Transplant Foundation Inc.$1K
- Integra Lifesciences Corporation$441
- Kerecis Limited$436
- Organogenesis Inc.$286
- plus $1K from 10 others
What the payments were for
- Travel & lodging$2,74434%
- Food & beverage$5,37866%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 19 | $2,649 |
| Stryker | 16 | $1,793 |
| Musculoskeletal Transplant Foundation Inc. | 13 | $1,260 |
| Integra Lifesciences Corporation | 6 | $441 |
| Kerecis Limited | 2 | $436 |
| Organogenesis Inc. | 4 | $286 |
| AbbVie(2 entities) | 7 | $283 |
| KCI USA, Inc. | 2 | $165 |
| Acera Surgical, Inc. | 2 | $147 |
| RTI Surgical, Inc | 1 | $146 |
| Davol Inc. | 1 | $144 |
| Solventum Corporation | 2 | $125 |
| Innovation Technologies Inc | 1 | $123 |
| Boston Scientific | 1 | $87 |
| Polynovo North America LLC | 1 | $19 |
| Medtronic | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$1,862
- SPY-PHI SYSTEM$1,239
- Kerecis Omega3 SurgiClose$872
- Kerecis Omega3 GraftGuide$436
- INTEGRA$432
- OviTex 2S$255
- PuraPly$248
- Kerecis Omega3 Marigen$218
- Kerecis Omega3 Wound$218
- Kerecis Omega3 Surgibind$218
- CORTIVA ALLOGRAFT DERMIS$146
- INTEGRA DERMAL REGENERATION TEMPLATE$144
- PRIMATRIX$144
- Phasix Mesh$144
- REVOLVE$138
- NATRELLE SALINE-FILLED BREAST IMPLANTS$138
- Restrata Wound Matrix$129
- Irrisept$123
- PREVENA$103
- 3M Cavilon$103
How this compares
$8,122 in reported general payments places this provider in the 70th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 20 | $325 |
| Pentoxifylline | 13 | $246 |
| Nystatin | 11 | $175 |
Paid to pharmacies, not to this prescriber.
Other surgery in San Antonio
- Richard PetersonSan Antonio$323K
- Joseph KaramSan Antonio$293K
- John PilcherSan Antonio$214K
- John MeterskySan Antonio$158K
- Kent van SickleSan Antonio$143K
- Richard EnglehardtSan Antonio$107K
- Guillermo Portillo RamilaSan Antonio$102K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.